menlo therapeutics logo

Menlo Therapeutics

Menlo Therapeutics is a late stage biopharmaceutical company focused on the development and commercialization of serlopitant for the treatment of pruritus, or itch, associated with various conditions

[stock_market_widget type=”leaderboard” template=”color-frame” color=”yellow” assets=”MNLO” api=”yf” style=”font-size: 15px”]

0
Management
0
Technology
0
Deals/Partnering
0
Research Pipeline
0
Funding
BioStartup's Score 0 / 50

KEY DETAILS

Websitehttp://www.menlotherapeutics.com
Founded2011
Disease Focus
Development Stage
STOCK CODENASDAQ: MNLO
Address
200 Cardinal Way, 2nd Floor, CA 94063
Redwood City
United States
Email
Contact Number
+1 650-486-1416

[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=”https://www.linkedin.com/company/menlo-therapeutics-inc” connections=”true” suffix=””]